Background Routine oral anticoagulation (OAC) is recommended for almost all high-risk
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …

Objectives The impact of oral anticoagulants (OACs) on the need of long-term care (LTC) in
the aging and multimorbid population of patients with atrial fibrillation (AF) is unknown. We …

Abstract Background Contemporary European data regarding patients with atrial fibrillation
(AF) allow us to assess the use of oral anticoagulants (OACs) and long-term outcomes …

Background Differences exist in oral anticoagulation (OAC) use between different
populations with atrial fibrillation (AF), which may be associated with varying outcomes …

Objectives Atrial fibrillation (AF) is a predominant risk factor of ischaemic stroke and
treatment with oral anticoagulants (OACs) is recommended in all patients with risk factors …

Aims To assess antithrombotic therapy choices in relation to patient age in a large, global
registry on atrial fibrillation (AF). Methods and results Global Registry on Long-Term Oral …

BACKGROUND Since 2010, the European Society of Cardiology has extended prescription
criteria for oral antithrombotic therapy (OAT) in atrial fibrillation (AF). Direct oral …

Aim The aim of this study is to examine temporal trends in the use oral anticoagulants (OAC)
as stroke prophylaxis in patients with atrial fibrillation (AF) and to examine factors associated …

Abstract Aims Direct oral anticoagulants (DOACs) have become the first-line antithrombotic
therapy in patients with non-valvular atrial fibrillation (NVAF). During this period, the …

Aims Adherence to guideline-directed oral anticoagulation (OAC) in patients with atrial
fibrillation (AF) improves outcomes, but limited data are available from China. We evaluated …